{"entity":{"type":"insider","cik":"0001581954","url":"/insider/0001581954","json_url":"/insider/0001581954.json","name":"Higgons John Duncan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":36,"first":"2014-01-23","last":"2021-04-16","span_basis":"filed_date"},"name_variants":[{"name":"Higgons John Duncan","source":"filing","n_filings":36,"first_seen":"2014-01-23","last_seen":"2021-04-16"}],"transactions":[{"id":4490683,"accession":"0001640455-21-000074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-21-000074","line_url":"/filing/0001640455-21-000074#line-1","is_derivative":false,"issuer_cik":"0001581954","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001581954","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","total_whole":"2,000","shares_owned_after":9713.0,"shares_owned_after_display":"9,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-15","filed_date":"2021-04-16","scope":"insider"},{"id":5080040,"accession":"0001640455-21-000070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-21-000070","line_url":"/filing/0001640455-21-000070#line-1","is_derivative":false,"issuer_cik":"0001581954","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001581954","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":12.8,"price_display":"12.80","price_state":"stated","total_value":2560.0,"total_display":"2,560.00","total_whole":"2,560","shares_owned_after":9913.0,"shares_owned_after_display":"9,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":4393179,"accession":"0001640455-21-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-21-000040","line_url":"/filing/0001640455-21-000040#line-1","is_derivative":false,"issuer_cik":"0001581954","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001581954","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":11.78,"price_display":"11.78","price_state":"stated","total_value":2356.0,"total_display":"2,356.00","total_whole":"2,356","shares_owned_after":10113.0,"shares_owned_after_display":"10,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":5123696,"accession":"0001640455-21-000017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001640455-21-000017","line_url":"/filing/0001640455-21-000017#line-2","is_derivative":false,"issuer_cik":"0001581954","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001581954","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":11.11,"price_display":"11.11","price_state":"stated","total_value":2222.0,"total_display":"2,222.00","total_whole":"2,222","shares_owned_after":10313.0,"shares_owned_after_display":"10,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-21","filed_date":"2021-01-22","scope":"insider"},{"id":5123695,"accession":"0001640455-21-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-21-000017","line_url":"/filing/0001640455-21-000017#line-1","is_derivative":false,"issuer_cik":"0001581954","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001581954","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":10513.0,"shares_owned_after_display":"10,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-20","filed_date":"2021-01-22","scope":"insider"},{"id":2534173,"accession":"0001640455-20-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-20-000002","line_url":"/filing/0001640455-20-000002#line-1","is_derivative":false,"issuer_cik":"0001581954","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001581954","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":8.11,"price_display":"8.11","price_state":"stated","total_value":12165.0,"total_display":"12,165.00","total_whole":"12,165","shares_owned_after":12013.0,"shares_owned_after_display":"12,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-06","filed_date":"2020-01-08","scope":"insider"},{"id":5313692,"accession":"0001104659-17-006178","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-006178","line_url":"/filing/0001104659-17-006178#line-1","is_derivative":false,"issuer_cik":"0001581954","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001581954","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6700.0,"shares_display":"6,700","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":107200.0,"total_display":"107,200.00","total_whole":"107,200","shares_owned_after":27025.0,"shares_owned_after_display":"27,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-01","filed_date":"2017-02-02","scope":"insider"},{"id":8085250,"accession":"0001209191-15-085756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-085756","line_url":"/filing/0001209191-15-085756#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":50.09,"price_display":"50.09","price_state":"stated","total_value":1001800.0,"total_display":"1,001,800.00","total_whole":"1,001,800","shares_owned_after":61835.0,"shares_owned_after_display":"61,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-17","scope":"insider"},{"id":8649551,"accession":"0001209191-15-080927","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-080927","line_url":"/filing/0001209191-15-080927#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":61.51,"price_display":"61.51","price_state":"stated","total_value":1230200.0,"total_display":"1,230,200.00","total_whole":"1,230,200","shares_owned_after":81835.0,"shares_owned_after_display":"81,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-16","filed_date":"2015-11-18","scope":"insider"},{"id":8676641,"accession":"0001209191-15-076128","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-076128","line_url":"/filing/0001209191-15-076128#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":71.04,"price_display":"71.04","price_state":"stated","total_value":1420800.0,"total_display":"1,420,800.00","total_whole":"1,420,800","shares_owned_after":81835.0,"shares_owned_after_display":"81,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-15","filed_date":"2015-10-19","scope":"insider"},{"id":8083823,"accession":"0001209191-15-071254","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-071254","line_url":"/filing/0001209191-15-071254#line-3","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":91.11,"price_display":"91.11","price_state":"stated","total_value":1822200.0,"total_display":"1,822,200.00","total_whole":"1,822,200","shares_owned_after":141835.0,"shares_owned_after_display":"141,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-15","filed_date":"2015-09-17","scope":"insider"},{"id":8375921,"accession":"0001209191-15-066876","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-066876","line_url":"/filing/0001209191-15-066876#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":92.24,"price_display":"92.24","price_state":"stated","total_value":1844800.0,"total_display":"1,844,800.00","total_whole":"1,844,800","shares_owned_after":131835.0,"shares_owned_after_display":"131,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-19","scope":"insider"},{"id":8541400,"accession":"0001209191-15-061528","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-061528","line_url":"/filing/0001209191-15-061528#line-3","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":114.02,"price_display":"114.02","price_state":"stated","total_value":2280400.0,"total_display":"2,280,400.00","total_whole":"2,280,400","shares_owned_after":121835.0,"shares_owned_after_display":"121,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-16","filed_date":"2015-07-17","scope":"insider"},{"id":8602766,"accession":"0001209191-15-053911","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-053911","line_url":"/filing/0001209191-15-053911#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":105.23,"price_display":"105.23","price_state":"stated","total_value":736610.0,"total_display":"736,610.00","total_whole":"736,610","shares_owned_after":121835.0,"shares_owned_after_display":"121,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-16","scope":"insider"},{"id":8774190,"accession":"0001209191-15-043985","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-043985","line_url":"/filing/0001209191-15-043985#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7417.0,"shares_display":"7,417","price_per_share":112.89,"price_display":"112.89","price_state":"stated","total_value":837305.13,"total_display":"837,305.13","total_whole":"837,305","shares_owned_after":98835.0,"shares_owned_after_display":"98,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-15","filed_date":"2015-05-18","scope":"insider"},{"id":8921310,"accession":"0001209191-15-035056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-035056","line_url":"/filing/0001209191-15-035056#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6583.0,"shares_display":"6,583","price_per_share":99.54,"price_display":"99.54","price_state":"stated","total_value":655271.82,"total_display":"655,271.82","total_whole":"655,272","shares_owned_after":106252.0,"shares_owned_after_display":"106,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-15","filed_date":"2015-04-17","scope":"insider"},{"id":8938085,"accession":"0001209191-15-027549","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-027549","line_url":"/filing/0001209191-15-027549#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":106.24,"price_display":"106.24","price_state":"stated","total_value":743680.0,"total_display":"743,680.00","total_whole":"743,680","shares_owned_after":112835.0,"shares_owned_after_display":"112,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-16","filed_date":"2015-03-18","scope":"insider"},{"id":8592907,"accession":"0001209191-15-002388","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-002388","line_url":"/filing/0001209191-15-002388#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":110.08,"price_display":"110.08","price_state":"stated","total_value":1320960.0,"total_display":"1,320,960.00","total_whole":"1,320,960","shares_owned_after":119835.0,"shares_owned_after_display":"119,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-06","scope":"insider"},{"id":8119792,"accession":"0001209191-15-002384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-002384","line_url":"/filing/0001209191-15-002384#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":110.08,"price_display":"110.08","price_state":"stated","total_value":1320960.0,"total_display":"1,320,960.00","total_whole":"1,320,960","shares_owned_after":119835.0,"shares_owned_after_display":"119,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-06","scope":"insider"},{"id":6237086,"accession":"0001209191-14-072460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-072460","line_url":"/filing/0001209191-14-072460#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":97.03,"price_display":"97.03","price_state":"stated","total_value":1164360.0,"total_display":"1,164,360.00","total_whole":"1,164,360","shares_owned_after":131835.0,"shares_owned_after_display":"131,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-02","scope":"insider"},{"id":6297211,"accession":"0001209191-14-066361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-066361","line_url":"/filing/0001209191-14-066361#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":81.71,"price_display":"81.71","price_state":"stated","total_value":1062230.0,"total_display":"1,062,230.00","total_whole":"1,062,230","shares_owned_after":143835.0,"shares_owned_after_display":"143,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-04","scope":"insider"},{"id":6388164,"accession":"0001209191-14-061808","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-061808","line_url":"/filing/0001209191-14-061808#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":60.07,"price_display":"60.07","price_state":"stated","total_value":780910.0,"total_display":"780,910.00","total_whole":"780,910","shares_owned_after":156835.0,"shares_owned_after_display":"156,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-03","scope":"insider"},{"id":6847069,"accession":"0001209191-14-055715","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-055715","line_url":"/filing/0001209191-14-055715#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":46.3,"price_display":"46.30","price_state":"stated","total_value":601900.0,"total_display":"601,900.00","total_whole":"601,900","shares_owned_after":169835.0,"shares_owned_after_display":"169,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-03","scope":"insider"},{"id":6476239,"accession":"0001209191-14-054841","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-054841","line_url":"/filing/0001209191-14-054841#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":45.05,"price_display":"45.05","price_state":"stated","total_value":225250.0,"total_display":"225,250.00","total_whole":"225,250","shares_owned_after":176090.0,"shares_owned_after_display":"176,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-26","filed_date":"2014-08-28","scope":"insider"},{"id":6846502,"accession":"0001209191-14-050727","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-050727","line_url":"/filing/0001209191-14-050727#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":39.09,"price_display":"39.09","price_state":"stated","total_value":273630.0,"total_display":"273,630.00","total_whole":"273,630","shares_owned_after":176090.0,"shares_owned_after_display":"176,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-01","filed_date":"2014-08-05","scope":"insider"},{"id":6266961,"accession":"0001209191-14-045507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-045507","line_url":"/filing/0001209191-14-045507#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":46.52,"price_display":"46.52","price_state":"stated","total_value":558240.0,"total_display":"558,240.00","total_whole":"558,240","shares_owned_after":176090.0,"shares_owned_after_display":"176,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-02","scope":"insider"},{"id":6559392,"accession":"0001209191-14-041697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-041697","line_url":"/filing/0001209191-14-041697#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":45.27,"price_display":"45.27","price_state":"stated","total_value":226350.0,"total_display":"226,350.00","total_whole":"226,350","shares_owned_after":188090.0,"shares_owned_after_display":"188,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-13","filed_date":"2014-06-16","scope":"insider"},{"id":6704735,"accession":"0001209191-14-039124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-039124","line_url":"/filing/0001209191-14-039124#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":129537.0,"total_display":"129,537.00","total_whole":"129,537","shares_owned_after":193090.0,"shares_owned_after_display":"193,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-03","filed_date":"2014-06-04","scope":"insider"},{"id":6704729,"accession":"0001209191-14-039124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-039124","line_url":"/filing/0001209191-14-039124#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":33.87,"price_display":"33.87","price_state":"stated","total_value":111771.0,"total_display":"111,771.00","total_whole":"111,771","shares_owned_after":196790.0,"shares_owned_after_display":"196,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-02","filed_date":"2014-06-04","scope":"insider"},{"id":6228941,"accession":"0001209191-14-031954","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-031954","line_url":"/filing/0001209191-14-031954#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":45.73,"price_display":"45.73","price_state":"stated","total_value":228650.0,"total_display":"228,650.00","total_whole":"228,650","shares_owned_after":200090.0,"shares_owned_after_display":"200,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-06","filed_date":"2014-05-07","scope":"insider"},{"id":6318198,"accession":"0001209191-14-031224","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-031224","line_url":"/filing/0001209191-14-031224#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":42.39,"price_display":"42.39","price_state":"stated","total_value":296730.0,"total_display":"296,730.00","total_whole":"296,730","shares_owned_after":205090.0,"shares_owned_after_display":"205,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-01","filed_date":"2014-05-05","scope":"insider"},{"id":6999912,"accession":"0001209191-14-026530","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-026530","line_url":"/filing/0001209191-14-026530#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":45.17,"price_display":"45.17","price_state":"stated","total_value":135510.0,"total_display":"135,510.00","total_whole":"135,510","shares_owned_after":209090.0,"shares_owned_after_display":"209,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-07","filed_date":"2014-04-08","scope":"insider"},{"id":6762759,"accession":"0001209191-14-025627","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-025627","line_url":"/filing/0001209191-14-025627#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":38.08,"price_display":"38.08","price_state":"stated","total_value":456960.0,"total_display":"456,960.00","total_whole":"456,960","shares_owned_after":209090.0,"shares_owned_after_display":"209,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-04-03","scope":"insider"},{"id":7011580,"accession":"0001209191-14-018464","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-018464","line_url":"/filing/0001209191-14-018464#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":45.1,"price_display":"45.10","price_state":"stated","total_value":405900.0,"total_display":"405,900.00","total_whole":"405,900","shares_owned_after":109090.0,"shares_owned_after_display":"109,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-03-07","scope":"insider"},{"id":7011576,"accession":"0001209191-14-018464","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-018464","line_url":"/filing/0001209191-14-018464#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5646.0,"shares_display":"5,646","price_per_share":35.54,"price_display":"35.54","price_state":"stated","total_value":200658.84,"total_display":"200,658.84","total_whole":"200,659","shares_owned_after":109090.0,"shares_owned_after_display":"109,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-06","filed_date":"2014-03-07","scope":"insider"},{"id":7088674,"accession":"0001209191-14-016819","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-016819","line_url":"/filing/0001209191-14-016819#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":29.854,"price_display":"29.85","price_state":"stated","total_value":238832.0,"total_display":"238,832.00","total_whole":"238,832","shares_owned_after":109090.0,"shares_owned_after_display":"109,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-03","filed_date":"2014-03-04","scope":"insider"},{"id":6555674,"accession":"0001209191-14-012589","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-012589","line_url":"/filing/0001209191-14-012589#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2354.0,"shares_display":"2,354","price_per_share":35.06,"price_display":"35.06","price_state":"stated","total_value":82531.24,"total_display":"82,531.24","total_whole":"82,531","shares_owned_after":109090.0,"shares_owned_after_display":"109,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-20","scope":"insider"},{"id":6312285,"accession":"0001209191-14-007368","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-007368","line_url":"/filing/0001209191-14-007368#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":25.966,"price_display":"25.97","price_state":"stated","total_value":207728.0,"total_display":"207,728.00","total_whole":"207,728","shares_owned_after":109090.0,"shares_owned_after_display":"109,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-03","filed_date":"2014-02-04","scope":"insider"},{"id":7011121,"accession":"0001209191-14-004638","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-004638","line_url":"/filing/0001209191-14-004638#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581954","owner_name":"Higgons John Duncan","owner_display_name":"Higgons John Duncan","owner_url":"/insider/0001581954","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":34.7108,"price_display":"34.71","price_state":"stated","total_value":416529.6,"total_display":"416,529.60","total_whole":"416,530","shares_owned_after":109090.0,"shares_owned_after_display":"109,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-21","filed_date":"2014-01-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":39,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":38,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":39},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001640455","name":"Jounce Therapeutics, Inc.","url":"/issuer/0001640455","role":"Director","n_filings":6,"first_seen":"2017-02-02","last_seen":"2021-04-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS INC","url":"/issuer/0001439222","role":"Officer (Chief Operating Officer)","n_filings":30,"first_seen":"2014-01-23","last_seen":"2015-12-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001581954","retrieved_at":"2026-08-26T22:12:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}